Hostname: page-component-78c5997874-j824f Total loading time: 0 Render date: 2024-11-17T14:50:00.878Z Has data issue: false hasContentIssue false

Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005

Published online by Cambridge University Press:  02 January 2015

Marya D. Zilberberg*
Affiliation:
School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts EviMed Research Group, Goshen, Massachusetts
Andrew F. Shorr
Affiliation:
Division of Pulmonary and Critical Care, Washington Hospital Center, Washington, D.C.
Marin H. Kollef
Affiliation:
Washington University School of Medicine, St. Louis, Missouri
*
EviMed Research Group, LLC, PO Box 303, Goshen, MA 01032 (Marya@EviMedGroup.org)

Abstract

In the United States, from January 1, 2000, through December 31, 2005, the incidence of candidemia-related hospitalization per 100,000 population rose by 52%, from 3.65 to 5.56 cases; and the incidence per 1,000 hospitalizations rose by 49%, from 0.28 to 0.42 cases. The proportion of all candidemia-related hospitalizations in which candidemia was the principal diagnosis remained stable at approximately 14%.

Type
Concise Communication
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Banerjee, SN, Emori, TG, Culver, DH. Secular trends in nosocomial primary bloodstream infections in the United States, 1980–1989. National Nosocomial Infections Surveillance System. Am J Med 1991;91:86S89S.CrossRefGoogle ScholarPubMed
2.Falagas, ME, Apostolou, KE, Pappas, VD. Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies. Eur J Clin Microbiol Infect Dis 2006;25:419425.Google Scholar
3.Morgan, J, Meltzer, MI, Plikaytis, BD, et al.Excess mortality, hospital stay, and cost due to candidemia: a case-control study using data from population-based candidemia surveillance. Infect Control Hosp Epidemiol 2005;26:540547.Google Scholar
4.Agency for Healthcare Research and Quality, Rockville, MD. Healthcare Cost and Utilization Project (HCUP) 2000–2004. HCUPnet. Available at: http://hcupnet.ahrq.gov/. Accessed October 1, 2007.Google Scholar
5.Snydman, DR. Shifting patterns in the epidemiology of nosocomial Candida infections. Chest 2003;123:500S503S.Google Scholar
6.Trick, WE, Fridkin, SK, Edwards, JR, et al.Secular trends of hospital acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis 2002;35:627630.CrossRefGoogle ScholarPubMed
7.Martin, GS, Mannino, DM, Eaton, S, et al.The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003;348:15461554.Google Scholar
8.Poikonen, E, Lyytikamen, O, Anttila, VJ, Ruutu, P. Candidemia in Finland, 1995–1999. Emerg Infect Dis 2003;9:985990.Google Scholar
9.Zaoutis, TE, Argon, J, Chu, J, et al.The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 2005;41:12321239.CrossRefGoogle ScholarPubMed